Literature DB >> 18715908

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Massimo Pizzato1, Elena Popova, Heinrich G Göttlinger.   

Abstract

Nef is an accessory protein of human immunodeficiency virus type 1 (HIV-1) that enhances the infectivity of progeny virions when expressed in virus-producing cells. The requirement for Nef for optimal infectivity is, at least in part, determined by the envelope (Env) glycoprotein, because it can be eliminated by pseudotyping HIV-1 particles with pH-dependent Env proteins. To investigate the role of Env in the function of Nef, we have examined the effect of Nef on the infectivity of Env-deficient HIV-1 particles pseudotyped with viral receptors for cells expressing cognate Env proteins. We found that Nef significantly enhances the infectivity of CD4-chemokine receptor pseudotypes for cells expressing HIV-1 Env. Nef also increased the infectivity of HIV-1 particles pseudotyped with Tva, the receptor for subgroup A Rous sarcoma virus (RSV-A), even though Nef had no effect if the pH-dependent Env protein of RSV-A was used for pseudotyping. However, Nef does not always enhance viral infectivity if the normal orientation of the Env-receptor interaction is reversed, because the entry of Env-deficient HIV-1 into cells expressing the vesicular stomatitis virus G protein was unaffected by Nef. Together, our results demonstrate that the presence of a viral Env protein during virus production is not required for the ability of Nef to increase viral infectivity. Furthermore, since the infectivity of Tva pseudotypes was blocked by inhibitors of endosomal acidification, we conclude that low-pH-dependent entry does not always bypass the requirement for Nef.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715908      PMCID: PMC2573167          DOI: 10.1128/JVI.01150-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions.

Authors:  J Silver; T Maudru; K Fujita; R Repaske
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

3.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.

Authors:  J V Garcia; A D Miller
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

4.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

5.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

Authors:  B S Stein; S D Gowda; J D Lifson; R C Penhallow; K G Bensch; E G Engleman
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

6.  The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4.

Authors:  J V Garcia; J Alfano; A D Miller
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases.

Authors:  A Helenius; M Marsh; J White
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

8.  CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals.

Authors:  R Mariani; J Skowronski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.

Authors:  M O McClure; M Marsh; R A Weiss
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

10.  Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.

Authors:  R E Benson; A Sanfridson; J S Ottinger; C Doyle; B R Cullen
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  17 in total

1.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

2.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

3.  MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.

Authors:  Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.

Authors:  Elena Sokolskaja; Silvia Olivari; Madeleine Zufferey; Caterina Strambio-De-Castillia; Massimo Pizzato; Jeremy Luban
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Authors:  Ajit Chande; Emilia Cristiana Cuccurullo; Annachiara Rosa; Serena Ziglio; Susan Carpenter; Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

7.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

9.  Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.

Authors:  Xianfeng Zhang; Tao Zhou; Jie Yang; Yumei Lin; Jing Shi; Xihe Zhang; Dylan A Frabutt; Xiangwei Zeng; Sunan Li; Patrick J Venta; Yong-Hui Zheng
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

10.  HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.

Authors:  Annachiara Rosa; Ajit Chande; Serena Ziglio; Veronica De Sanctis; Roberto Bertorelli; Shih Lin Goh; Sean M McCauley; Anetta Nowosielska; Stylianos E Antonarakis; Jeremy Luban; Federico Andrea Santoni; Massimo Pizzato
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.